Lioresal and Decongestant - a phase IV clinical study of FDA data
We study 19,907 people who take Lioresal or have Decongestant. No report of Decongestant is found in people who take Lioresal.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Lioresal?
Lioresal has active ingredients of baclofen. It is often used in multiple sclerosis. eHealthMe is studying from 19,861 Lioresal users for its effectiveness, alternative drugs and more.
What is Decongestant?
Decongestant: no further information found.
Do you take Lioresal and have Decongestant?Check whether Decongestant is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Decongestant and when was it recovered:
Expand to all the drugs that have ingredients of baclofen:
Alternative drugs to, pros and cons of Lioresal:
- Lioresal (19,861 reports)
Decongestant treatments and more:
- Decongestant (46 reports)
COVID vaccines that are related to Decongestant:
- Decongestant in Moderna COVID Vaccine
- Decongestant in Pfizer BioNTech Covid Vaccine
- Decongestant in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Decongestant:
All the conditions that are associated with Decongestant:
How the study uses the data?
The study uses data from the FDA. It is based on baclofen (the active ingredients of Lioresal) and Lioresal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cimetidine and Risedronate Sodium drug interaction - now
- Temovate and Aspartate Aminotransferase Increased - 10 seconds ago
- Clexane and Otitis Media - 11 seconds ago
- Phenazopyridine Hcl and Pleural Effusion - 13 seconds ago
- Wellbutrin Xl and Pseudotumor Cerebri - 23 seconds ago
- Trovan and Dry Skin - 30 seconds ago
- Humulin R and Swollen Tongue - 31 seconds ago
- Retin-A Micro vs. Tri-Sprintec - 31 seconds ago
- Campath and Atrial Fibrillation/Flutter - 33 seconds ago
- Metochlopramide and Multi-Organ Failure - 37 seconds ago